Jin Medical International Ltd.(ZJYL)

Medical - Instruments & Supplies · Changzhou, JS

$1.99+0.01 (+0.51%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T21:43:35.599Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:43:35.599Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 15,576,490
Total debt · period ending 2026-03-31: 20,580,060
Cash · period ending 2026-03-31: 9,083,602
TTM free cash flow · period ending 2026-03-31: N/A

FMP input reference: 08a81e5feebad721ee05cca7d6a51b618a8c436619bf2c78a545ff1cd4f886dd

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ZJYL EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

ZJYL Competitors' EV/FCF Ratio

ZJYL

Jin Medical International Ltd.

Current

Market Cap

$15.58M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALLR

Allarity Therapeutics, Inc.

vs ZJYL

Market Cap

$15.68M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCDA

BioCardia, Inc.

vs ZJYL

Market Cap

$15.78M

EV/FCF Ratio

N/A

TTM Avg

79.94x

3Y Avg

79.62x

5Y Avg

79.62x

COCP

Cocrystal Pharma, Inc.

vs ZJYL

Market Cap

$15.30M

EV/FCF Ratio

N/A

TTM Avg

97.85x

3Y Avg

97.85x

5Y Avg

97.85x

KTTA

Pasithea Therapeutics Corp.

vs ZJYL

Market Cap

$14.94M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPTI

Karyopharm Therapeutics Inc.

vs ZJYL

Market Cap

$14.73M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DYAI

Dyadic International, Inc.

vs ZJYL

Market Cap

$16.52M

EV/FCF Ratio

N/A

TTM Avg

47.06x

3Y Avg

54.97x

5Y Avg

55.49x

BNGO

Bionano Genomics, Inc.

vs ZJYL

Market Cap

$16.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HIND

Vyome Holdings, Inc.

vs ZJYL

Market Cap

$14.46M

EV/FCF Ratio

12.56x

TTM Avg

13.15x

3Y Avg

13.15x

5Y Avg

13.15x

PTN

Palatin Technologies, Inc.

vs ZJYL

Market Cap

$16.74M

EV/FCF Ratio

N/A

TTM Avg

2075.17x

3Y Avg

2570.19x

5Y Avg

2570.19x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Jin Medical International Ltd. (ZJYL)	$15.58M	N/A	N/A	N/A	N/A
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.68M	N/A	N/A	N/A	N/A
BioCardia, Inc. (BCDA)vs ›	$15.78M	N/A	79.94x	79.62x	79.62x
Cocrystal Pharma, Inc. (COCP)vs ›	$15.30M	N/A	97.85x	97.85x	97.85x
Pasithea Therapeutics Corp. (KTTA)vs ›	$14.94M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.73M	N/A	N/A	N/A	N/A
Dyadic International, Inc. (DYAI)vs ›	$16.52M	N/A	47.06x	54.97x	55.49x
Bionano Genomics, Inc. (BNGO)vs ›	$16.64M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$14.46M	12.56x	13.15x	13.15x	13.15x
Palatin Technologies, Inc. (PTN)vs ›	$16.74M	N/A	2075.17x	2570.19x	2570.19x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

ZJYL EV/FCF Ratio Metrics

ZJYL Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics